WeVote
Log In

Bill

Bill

SB 518

Medical marijuana packaging; requiring certain warnings on labels. Effective date.

2026 Regular Session Introduced by Jerry Alvord and 1 co-sponsor

Oklahoma requires medical marijuana products to display specific warning labels on packaging to inform patients of health and safety information before purchase and use.

Becomes law without Governor's signature 05/21/2025
0
WeVote Research Nonpartisan
Bill Summary · SB 518

Legislative bill overview

SB 518 mandates specific warning labels on medical marijuana product packaging in Oklahoma. The bill establishes labeling requirements that products must meet before distribution to patients, and became law without the Governor's signature on May 21, 2025.

Why is this important

Clear labeling requirements protect medical marijuana patients by ensuring they have access to standardized safety information about products they're consuming. This aligns Oklahoma's medical cannabis program with public health standards similar to other regulated substances and helps prevent accidental misuse or adverse health interactions.

Potential points of contention

  • Warning specificity debate: Disagreement may exist over which warnings are most critical (potency levels, side effects, drug interactions, age restrictions) and whether mandated warnings are sufficiently evidence-based
  • Industry compliance costs: Packaging requirement changes impose costs on producers and may create inventory challenges during implementation timelines
  • Effectiveness questions: Some stakeholders may argue that label warnings have limited real-world impact if patients don't read them or if warnings create liability concerns for medical providers recommending the products

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.